The recent COVID-19 (coronavirus) outbreak has caused significant concern amongst patients that are on immunosuppressive drugs for their arthritis. At Addenbrooke's Hospital, we are working hard to put together a guide for patients and this should be published on the Addenbrooke's Hospital Rheumatology page on 24/03/20.
Useful information can be found on the NHS website by following THIS link. For those currently on treatment, please note the advice below:
· Heart attack (myocardial infarction);
· Chronic heart failure;
· Hypertension (high blood pressure);
· Chronic lung diseases (e.g. asthma, COPD, bronchiectasis, fibrosis, interstitial lung disease, Bronchiolitis Obliterans, aspergillosis);
· Peripheral vascular disease (blocked arteries in your limbs)
· Stroke (cerebrovascular accident/CVA) or TIA (transient ischaemic attack [‘mini-stroke’]);
· Dementia;
· Chronic liver disease (e.g. Primary Biliary Cirrhosis, Fibrosis, Cirrhosis [but not short-lived abnormalities of blood tests])
· Diabetes;
· Chronic kidney disease – qualified as: ‘on, or being considered for, dialysis, or having had a kidney transplant);
· Recent cancer (i.e. you are still being cared for under the cancer team at the hospital and have not yet been told you ‘are cured’);
· HIV positive.
DR ANSHUMAN MALAVIYA CONSULTANT RHEUMATOLOGIST
Copyright © 2018 Chelmsford Rheumatology - All Rights Reserved.
Powered by GoDaddy